The signaling pathway of EpCAM complex proteins in the regulation and enhancement of OSKM-mediated pluripotency reprogramming
Model of the signaling pathway of EpCAM complex proteins in the regulation and enhancement of OSKM-mediated pluripotency reprogramming. EpCAM and OSKM are able to cross-regulate the expression of each other and form a positive feedback loop to enhance the reprogramming efficiency. Step 1, exogenous OSKM factors activate the expression of endogenous OSKM genes, and EpCAM as well as Cldn7. Step 2, EpCAM and Cldn7 are transported to plasma membrane and associate with other members of the complex. Step 3, EpCAM is cleaved by Psen2 and Adam17 to relieve EpICD, which is subsequently transported into the nucleus. Step 4, EpICD forms a complex with other proteins to directly or indirectly enhance the expression of endogenous OSKM genes, such as Oct4 and c-Myc; on the other hand, EpICD-containing complex may down-regulate the expression of p53 and its downstream genes, such as p21. It has been shown that p53 can bind the promoter of EpCAM and inhibit its activity (). Therefore, EpICD can positively regulate its own expression. Red lines, findings in this study; dashed lines and question marks, a possible but unproved effect.